The Onset of de novo Hepatocellular Carcinoma after Liver Transplantation can be both of Donor and Recipient origin. A Case Report

被引:1
作者
Tame, Mariarosa [1 ]
Calvanese, Claudio [1 ]
Cucchetti, Alessandro [1 ]
Gruppioni, Elisa [2 ]
Colecchia, Antonio [1 ]
Bazzoli, Franco [1 ]
机构
[1] Alma Mater Studiorum Univ Bologna, Dept Med & Surg Sci, Bologna, Italy
[2] Univ Bologna, S Orsola M Malpighi Hosp, Lab Oncol & Transplantat Mol Pathol, Bologna, Italy
关键词
de novo HCC; epithelial chimerism; HCC recurrence; hepatocellular carcinoma; liver transplantation; microsatellite analysis; RECURRENT;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The occurrence of de novo hepatocellular carcinoma after liver transplantation is a rare event with only few cases reported in the literature. In a post liver transplantation setting distinguishing between a de novo hepatocellular carcinoma from recurrence should be tested with molecular analysis such as fluorescent in situ hybridization (for sex chromosomes) or microsatellite analysis. Nevertheless, a certain degree of epithelial chimerism between recipient and donor tissues could be responsible for the development of de novo hepatocellular carcinoma of recipient origin. We report two cases of de novo hepatocellular carcinoma after liver transplantation. The first one occurred in a patient receiving transplantation for hepatitis C related cirrhosis and hepatocellular carcinoma. A de novo hepatocellular carcinoma developed five years after transplantation and microsatellite analysis revealed the donor origin of the neoplasia. The second one occurred in a patient who received transplantation for secondary sclerosing cholangitis. Hepatocellular carcinoma was found six years after transplantation. Both microsatellite analysis and fluorescent in situ hybridization revealed the recipient origin of the tumor, potentially due to tissue chimerism.
引用
收藏
页码:387 / 389
页数:3
相关论文
共 50 条
  • [31] Recurrent Hepatocellular Carcinoma in the Right Adrenal Gland 11 Years After Liver Transplantation for Hepatocellular Carcinoma: a Case Report and Literature Review
    Sormaz, Ismail Cem
    Yegen, Gulcin
    Akyuz, Filiz
    Tunca, Fatih
    Senyurek, Yasemin Giles
    INDIAN JOURNAL OF SURGERY, 2017, 79 (05) : 450 - 454
  • [32] Recurrent Hepatocellular Carcinoma in the Right Adrenal Gland 11 Years After Liver Transplantation for Hepatocellular Carcinoma: a Case Report and Literature Review
    Ismail Cem Sormaz
    Gülçin Yegen
    Filiz Akyuz
    Fatih Tunca
    Yasemin Giles Şenyürek
    Indian Journal of Surgery, 2017, 79 : 450 - 454
  • [33] A case of primary (de novo) carcinoma of the uterine cervix after cadaveric orthotopic liver transplantation
    Teke, Zafer
    Bostanci, Erdal Birol
    Ulas, Murat
    Akoglu, Musa
    TURKISH JOURNAL OF SURGERY, 2011, 27 (03) : 159 - 163
  • [34] The impact of rituximab prophylaxis on hepatocellular carcinoma recurrence after living donor liver transplantation
    Kamo, Naoko
    Yagi, Shintaro
    HEPATOMA RESEARCH, 2021, 7
  • [35] Recipient-Donor Sex Constellation in Liver Transplantation for Hepatocellular Carcinoma-An ELTR Study
    Magyar, Christian Tibor Josef
    Arteaga, Noah Free
    Germani, Giacomo
    Karam, Vincent Hassan
    Adam, Rene
    Romagnoli, Renato
    De Simone, Paolo
    Robin, Fabien
    Cherqui, Daniel
    Bosca, Andrea
    Mazzaferro, Vincenzo
    Fundora, Yiliam
    Heneghan, Michael
    Llado, Laura
    Lesurtel, Mickael
    Cescon, Matteo
    Mirza, Darius
    Cavelti, Andrea
    Christen, Lucienne
    Storni, Federico
    Kim-Fuchs, Corina
    Lachenmayer, Anja
    Beldi, Guido
    Candinas, Daniel
    Radu, Iuliana-Pompilia
    Schwacha-Eipper, Birgit
    Berzigotti, Annalisa
    Banz, Vanessa
    LIVER INTERNATIONAL, 2025, 45 (01)
  • [36] Successful pancreatoduodenectomy of de novo duodenal malignancy after orthotopic liver transplantation: A case report
    Ji, Linhua
    Xu, Danhua
    Zhu, Chunchao
    Xu, Jia
    Cao, Hui
    Zhao, Gang
    FRONTIERS IN SURGERY, 2023, 9
  • [37] Efficacy and Safety of Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Living Donor Liver Transplantation: A Report of Two Cases
    Ichida, Akihiko
    Akamatsu, Nobuhisa
    Nagata, Rihito
    Mihara, Yuichiro
    Kawaguchi, Yoshikuni
    Bae, Sung Kwan
    Ishizawa, Takeaki
    Kaneko, Junichi
    Arita, Junichi
    Hasegawa, Kiyoshi
    ANTICANCER RESEARCH, 2022, 42 (02) : 1161 - 1167
  • [38] De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: Long-term outcomes and side effects
    Toso, Christian
    Meeberg, Glenda A.
    Bigam, David L.
    Oberholzer, Jose
    Shapiro, A. M. James
    Gutfreund, Klaus
    Ma, Mang M.
    Mason, Andrew L.
    Wong, Winnie W. S.
    Bain, Vincent G.
    Kneteman, Norman M.
    TRANSPLANTATION, 2007, 83 (09) : 1162 - 1168
  • [39] Can response to TACE predict survival after liver transplantation in patients with hepatocellular carcinoma?
    Martin, Paul
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2007, 4 (10): : 540 - 541
  • [40] Can the Dropout Risk of Candidates with Hepatocellular Carcinoma Predict Survival after Liver Transplantation?
    Cucchetti, A.
    Cescon, M.
    Bertuzzo, V.
    Bigonzi, E.
    Ercolani, G.
    Morelli, M. C.
    Ravaioli, M.
    Pinna, A. D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (08) : 1696 - 1704